David Schnell is listed as a director on 34 SEC Form D filings by 9 issuers between Apr 2009 and Jun 2019. Largest by amount reported sold: NGM BIOPHARMACEUTICALS INC (South San Francisco, CA — biotechnology — 2009–2015; $106M reported sold to 28 investors), Ajax Therapeutics, Inc. (New York, NY — biotechnology — 2019; $95M reported sold to 21 investors), LUX BIOSCIENCES INC (Jersey City, NJ — biotechnology — 2009–2012; $37.9M reported sold to 10 investors), KYTHERA BIOPHARMACEUTICALS INC (Calabasas, CA — pharmaceuticals — 2011; $37.4M reported sold to 20 investors), ALVINE PHARMACEUTICALS INC (San Carlos, CA — other health care — 2013; $26.5M reported sold to 18 investors) and 4 more (all listed below).
What this means A repeat sponsor — 9 separate companies raised money with this person listed as director, over about 10 years. Across those companies the filings report $366.2M sold in total.
Listed alongside Donald J. Hayden (12 shared filings), Martin Vogelbaum (11 shared filings), David Goeddel (10 shared filings), Jin-Long Chen (10 shared filings), Peter Svennilson (10 shared filings) and 67 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around David. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AK, AL, AR, AZ, CA, CT, DE, FINRA, GA, HI, ID, IL, KS, KY, LA, MA, MD, ME, MI, MO, MS, MT, NASAA, NC, ND, NH, NM, NV, OK, OR, PA, RI, SC, SD, TN, TX, VT, WA, WI, WV, WY) — 9 bankruptcy cases matching the name listed in Key records below.
What this means 9 records came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.
We compared 34 public filings for David Schnell and found 13 differences, 5 worth asking the sponsor about: 5 bankruptcy cases name the subject or team members; Amount sold went down between filings; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.